Portal vein thrombosis — a literature review and our own clinical observations
https://doi.org/10.31146/1682-8658-ecg-181-9-55-62
Abstract
The portal vein thrombosis (PVT) is a partial or complete occlusion of blood flow through the portal vein that occurs due to the presence of a blood clot in its lumen. Currently, PVT has become more common in the clinic of internal diseases. PVT can be caused by many factors, among which local and systemic. Systemic factors include congenital and acquired thrombophilia. Local factors include inflammatory, infectious, and oncological diseases of the abdominal organs. One of the most likely causes of PVT is currently being considered liver cirrhosis. The article presents the literature data, clinical guidelines for managing patients with PVT in the discussion of three own clinical cases of patients with PVT, which were caused by various diseases.
About the Authors
E. V. Luzina
Chita State Medical Academy of the Ministry of Health of Russia
Russian Federation
Russian Federation
Elena V. Luzina, MD, PhD, associate Professor of the Department of Therapy faculty of advanced training and professional retraining of specialists; Chairman of the TRANS-Baikal scientifi c society of gastroenterologists
eLibrary SPIN: 6748–9361
Chita
E. A. Tomina
Chita State Medical Academy of the Ministry of Health of Russia
Russian Federation
Russian Federation
Elena A. Tomina, MD, PhD, assistant of the Department of Therapy faculty of advanced training and professional retraining of specialists
Chita
S. I. Shchadneva
Chita State Medical Academy of the Ministry of Health of Russia
Russian Federation
Russian Federation
Snezhana I. Shchadneva, MD, PhD, associate Professor of the Department of Hospital Therapy and Endocrinology
Chita
N. V. Lareva
Chita State Medical Academy of the Ministry of Health of Russia
Russian Federation
Russian Federation
Nataliya V. Lareva, MD, PhD, Professor, Vice-rector for research, Head of the Department of Therapy faculty of advanced training and professional retraining of specialists
eLibrary SPIN: 1228–6205
Chita
References
1. Sharma A.M., Zhu D., Henry Z. Portal vein thrombosis: When to treat and how? Vasc Med. 2016 Feb; 21(1): 61–9.
2. Клинические рекомендации EASL: заболевания сосудов печени. Journal of Hepatology. Русское издание 2016; Т. 2(1): 87–114. Clinical guidelines for EASL: vascular disease of the liver. Journal of Hepatology. Russian edition. 2016; 2(1): 87–114. (in Russ.)
3. Qi X., De Stefano V., Wang J. et al. Prevalence of inherited antithrombin, protein C, and protein S deficiencies in portal vein system thrombosis and Budd-Chiari syndrome: a systematic review and meta-analysis of observational studies. Journal of Gastroenterology and Hepatology. 2013; 28(3): 432–442.
4. Ozturk O., Eldem G., Peynircioglu B. et al. Outcomes of partial splenic embolization in patients with massive splenomegaly due to idiopathic portal hypertension. World J Gastroenterol. 2016; 22(43): 9623–9963.
5. Lacroi x R., Dubois C., Leroyer A. S. et al. Revisited role of microparticles in arterial and venous thrombosis. J Thromb Haemost 2013; 11(1): 24–35.
6. Сушинская Т.В., Стеклов Н. И., Доброхотова Ю. Э. Гемостаз и рак-ассоциированный тромбоз: современная профилактика и лечение Онкология. Журнал им. П. А. Герцена 2018; 7(4): 64–72. Sushinskaya T. V., Stuklov N. I., Dobrokhotova Yu. E. Hemostasis and cancer-associated thrombosis: modern prevention and treatment. Oncology. Journal named after P. A. Herzen. 2018; 7(4): 64–72. (in Russ.)
7. Кораблев Р. В. Васильев А. Г. Неоангиогенез и опухолевый рост. Российские биомедицинские исследования. 2017; 2(4): 3–10. Korablev R. V., Vasilyev A. G. Neoangiogenesis and tumor growth. Russian biomedical researches. 2017; 2(4): 3–10. (in Russ.)
8. Бакулин И.Г., Шаликиани Н. В. Тромоз воротной вены: современный взгляд на вопросы этиопатогенеза, профилактики и лечения. Эффективная фармакотерапия 2014; 43: 64–69. Bakulin I. G. Shaliciani N. B. Portal vein thrombosis: a modern view on the issues of etiopathogenesis, prevention and treatment. Effective pharmacotherapy. 2014; 43: 64–69. (in Russ.)
9. Bosch F. X., Ribes J., Díaz M. et al. Primary liver cancer: worldwide incidence and trends. Gastroenterology. 2004; 127(5 Suppl 1): 5–16.
10. Giorgio A., Calisti G., Montesarchio L. et al. Hepatocellular carcinoma invading portal venous system in cirrhosis: long-term results of percutaneous radiofrequency ablation of both the nodule and portal vein tumor thrombus. A case control study. Anticancer Res. 2014; 34(11): 6785–90.
11. Amitrano L. et al. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. Journal of Hepatology 2006; 40(5): 736–741.
12. Harding D.J., Perera M. T., Chen F. et al. Portal vein thrombosis in cirrhosis: Controversies and latest developments. World J Gastroenterol. 2015 Jun 14; 21(22): 6769–84.
13. Надинская М.Ю., Кодзоева Х. Б., Ульянова К. А. и др. Факторы риска, ассоциированные с тромбозом воротной вены, у больных циррозом печени: исследование случай-контроль. Терапевтический архив 2019; 91(2): 73–81. DOI: 10.26442/00403660.2019.02. 000153. Nadinskaia M. Yu., Kodzoeva Kh.B., Ulyanova K. A., et al. Risk factors associated with portal vein thrombosis in liver cirrhosis: A case-control study. Therapeutic Archive. 2019; 91(2): 73–81. DOI: 10.26442/00403660.2019.02.000153 (in Russ.)
14. Подлесских М.Н., Цодиков Г. В., Волчкова Е. В. и др. Тромбоз воротной вены в практике гастроэнтеролога. Фарматека 2010; 2: 54–60. Podlesskih M., Tsodikov G., Volchkova E. et al. Portal vein thrombosis in the practice of gastroenterologist. Pharmateca. 2010; 2(196): 54–60. (in Russ.)
15. Dhillon P.K., Adams M. J. Thrombosis in systemic lupus erythematosus: role of impaired fibrinolysis. Semin Thromb Hemost. 2013; 39(4): 434-440. doi:10.1055/s-0033–1334484
16. Решетняк Т. М. Антифосфолипидный синдром: диагностика и клинические проявления (лекция). Научно-практическая ревматология 2014; 52(1): 56–71. Reshetnyak T. M. Antiphospholipid syndrome: diagnosis and clinical manifestations (lecture). Scientific and practical rheumatology. 2014; 52(1): 56–71. (in Russ.)
17. Pons-Estel G.J., Andreoli L., Scanzi F. et al. The antiphospholipid syndrome in patients with systemic lupus erythematosus. J Autoimmun. 2017; 76: 10-20. doi:10.1016/j.jaut.2016.10.004
18. Решетняк Т. М. Антифосфолипидный синдром: современное состояние и задачи на будущее. Научнопрактическая ревматология. 2013; 51(1): 11–14. Reshetnyak T. M. Antiphospholipid syndrome: current state and challenges for the future. Scientific and practical rheumatology. 2013; 51(1): 11–14. (in Russ.)
19. Башлакова Н. А., Шубенок Д. В., Кравчук З. И. и др. Диагностическая значимость лабораторных маркеров антифосфолипидного синдрома при системной красной волчанке. Проблемы здоровья и экологии 2011; 5: 18–20. Bashlakova N. A., Shubenok D. V., Kravchuk Z. I. et al. Diagnostic significance of laboratory markers of antiphospholipid syndrome in systemic lupus erythematosus. Health and environmental issues. 2011; 5: 18–20. (in Russ.)
20. Cavallasca J. A., Musuruana J. L., Granero G. Portal vein thrombosis in systemic lupus erythematosus associated with anticardiolipin antibodies. Int J Rheum Dis. 2011; 14(1): e5-e7. doi:10.1111/j.1756–185X.2010.01576.x
21. Pons-Estel G. J., Andreoli L., Scanzi F. et al. The antiphospholipid syndrome in patients with systemic lupus erythematosus. J Autoimmun. 2017; 76: 10-20. doi:10.1016/j.jaut.2016.10.004
22. Loff redo L., Pastori D., Farcomeni A., Violi F. Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis: A Systematic Review and Metaanalysis. Gastroenterology. 2017 Aug; 153(2): 480–487.
23. O’Leary J. G., Greenberg C. S., Patton H. M., Caldwell S. H. AGA Clinical Practice Update: Coagulation in Cirrhosis. Gastroenterology. 2019 Jul; 157(1): 34–43.
Review
For citations:
Luzina E.V., Tomina E.A., Shchadneva S.I., Lareva N.V. Portal vein thrombosis — a literature review and our own clinical observations. Experimental and Clinical Gastroenterology. 2020;(9):55-62. (In Russ.) https://doi.org/10.31146/1682-8658-ecg-181-9-55-62
Views:
411
Email this article 